Cardiac sympathetic activity and lethal arrhythmic events: insight into bell-shaped relationship between
Kenichi Nakajima1, Tomoaki Nakata2, Takahiro Doi3
1Department of Nuclear Medicine/Functional imaging and Artificial Intelligence, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-8640, Japan. nakajima@med.kanazawa-u.ac.jp.
Insights
The relationship between cardiac 123I-meta-iodobenzylguanidine (mIBG) uptake and lethal arrhythmic events (ArE) shows a bell-shaped curve in certain chronic heart failure patients. This finding helps identify those at higher risk for ArE.
Area of Science:
- Cardiology
- Nuclear Medicine
- Medical Imaging
Background:
- 123I-meta-iodobenzylguanidine (mIBG) is used in chronic heart failure (CHF) patients.
- The link between mIBG cardiac activity and lethal arrhythmic events (ArE) requires further clarification.
Purpose of the Study:
- To investigate the relationship between cardiac 123I-mIBG activity and ArE in Japanese and European cohorts.
- To identify patient subgroups at higher risk for ArE based on mIBG imaging parameters.
Main Methods:
- Analysis of heart-to-mediastinum (H/M) count ratios and washout rates (WRs) from planar 123I-mIBG imaging in 827 CHF patients.
- Definition of ArE including sudden cardiac death, arrhythmic death, and potentially lethal events.
- Machine learning models incorporating 13 clinical variables to simulate ArE rates.
Main Results:
- A bell-shaped relationship between H/M ratios and ArE incidence was observed in the European cohort and in patients with NYHA classes II/III combined.
- This bell-shaped pattern was particularly evident in patients with high mIBG WR (>15%) and ischemic etiology.
- Machine learning predictions confirmed a bell-shaped ArE risk curve in NYHA class II/III patients.
Conclusions:
- The relationship between cardiac 123I-mIBG activity and ArE is patient-dependent.
- A bell-shaped relationship in specific patient groups (NYHA II/III, high WR, ischemic etiology) aids in identifying high-risk individuals for ArE.
Background:
123I-meta-iodobenzylguanidine (mIBG) has been applied to patients with chronic heart failure (CHF). However, the relationship between 123I-mIBG activity and lethal arrhythmic events (ArE) is not well defined. This study aimed to determine this relationship in Japanese and European cohorts.
Results:
We calculated heart-to-mediastinum (H/M) count ratios and washout rates (WRs) of 827 patients using planar 123I-mIBG imaging. We defined ArEs as sudden cardiac death, arrhythmic death, and potentially lethal events such as sustained ventricular tachycardia, cardiac arrest with resuscitation, and appropriate implantable cardioverter defibrillator (ICD) discharge, either from a single ICD or as part of a cardiac resynchronization therapy device (CRTD). We analyzed the incidence of ArE with respect to H/M ratios, WRs and New York Heart Association (NYHA) functional classes among Japanese (J; n = 581) and European (E; n = 246) cohorts. We also simulated ArE rates versus H/M ratios under specific conditions using a machine-learning model incorporating 13 clinical variables. Consecutive patients with CHF were selected in group J, whereas group E comprised candidates for cardiac electronic devices. Groups J and E mostly comprised patients with NYHA functional classes I/II (95%) and II/III (91%), respectively, and 21% and 72% were respectively implanted with ICD/CRTD devices. The ArE rate increased with lower H/M ratios in group J, but the relationship was bell-shaped, with a high ArE rate within the intermediate H/M range, in group E. This bell-shaped curve was also evident in patients with NYHA classes II/III in the combined J and E groups, particularly in those with a high (> 15%) mIBG WR and with ischemic, but not in those with non-ischemic etiologies. Machine learning-based prediction of ArE risk aligned with these findings, indicating a bell-shaped curve in NYHA class II/III but not in class I.
Conclusions:
The relationship between cardiac 123I-mIBG activity and lethal arrhythmic events is influenced by the background of patients. The bell-shaped relationship in NYHA classes II/III, high WR, and ischemic etiology likely aids in identifying patients at high risk for ArEs.
More Related Videos
Related Concept Videos
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Heart Failure Drugs: Inotropic Agents
Mechanism of Cardiac Arrhythmias
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...


